Instanyl® Non-Interventional Study

Update Il y a 4 ans
Reference: NCT01045603

Woman and Man

Extract

The aim of this study is to describe the use of Instanyl® (Intranasal fentanyl spray) in the treatment of breakthrough pain (BTP) in cancer patients by success of dose titration and distribution of dose strength. Data will be collected at three different time points over a 3 month period.


Inclusion criteria

  • Breakthrough Cancer Pain


Links